 |
Articles: Drug/Product Alerts |
Prior Articles
Myriad Genetics, Inc. Receives Approval From New York Stock Exchange to Proceed With New Listing
Myriad, 04/16/09
Free full text
Cell Therapeutics Initiating Rolling NDA Submission for Pixantrone
Cell Therapeutics, 04/15/09
Free full text
Myriad Applauds New ACOG Guidelines for Hereditary Breast and Ovarian Cancer
Myriad, 04/15/09
Free full text
Mylan Confirms First-to-File Patent Challenge Relating to Xeloda Cancer Treatment
Mylan, 04/15/09 Desvenlafaxine: a new antidepressant or just another one
Expert Opinion in Pharmacotherapy, 04/14/09 Olde Cape Cod Foods issues Allergy Alert on Undeclared Fish Protein (Anchovy) in Product
FDA Drug Alerts, 04/13/09
Free full text
Budesonide/Formoterol (Symbicort): Corticosteroid/LABA combination approved for the maintenance treatment of COPD
Formulary, 04/10/09 FDA Advisory Committee recommendation on SEROQUEL XR Supplemental New Drug Applications
AstraZeneca, 04/09/09
Free full text
FDA Approves Coartem Tablets to Treat Malaria
FDA Press Releases, 04/09/09
Free full text
Coartem receives FDA approval becoming first artemisinin-based combination treatment (ACT) for malaria in the US
Novartis, 04/09/09
Free full text
Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
Watson Pharmaceuticals, 04/08/09
Free full text
Biovail Announces U.S. Availability of Aplenzin(TM) Tablets
BioVail Corporation, 04/08/09
Free full text
MediGene: USPTO Grants Extension of a Patent on Veregen
MediGene, 04/08/09
Free full text
Taro Receives Final FDA Approval for Carbamazepine Extended-Release Tablets
Taro Pharmaceuticals USA, 04/06/09
Free full text
Teva Announces Approval of Generic Yaz Tablets
Teva Pharmaceutical Industries, 04/02/09
Free full text
FDA Approves Generic Topamax to Prevent Seizures
FDA Press Releases, 04/02/09
Free full text
ONGLYZA (saxagliptin) Cardiovascular Profile Acceptable According to FDA Advisory Committee
Bristol Myers-Squibb Company, 04/02/09
Free full text
Strativa pharmaceuticals acquires worldwide rights to nascobal (cyanocobalamin, usp) nasal spray from qol medical
Par Pharmaceutical, 04/02/09 A coreceptor CCR5 antagonist for management of HIV infection
American Journal of Health-System Pharmacy, 04/01/09 Synflorix, GlaxoSmithKline's pneumococcal vaccine, receives European authorisation
GlaxoSmithKline, 04/01/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
143 Available Pages
|
|
